{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:11:51Z","timestamp":1789506711654,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003093","name":"Ministry of Higher Education, Malaysia","doi-asserted-by":"publisher","award":["MO002L-2021"],"award-info":[{"award-number":["MO002L-2021"]}],"id":[{"id":"10.13039\/501100003093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003093","name":"Ministry of Higher Education, Malaysia","doi-asserted-by":"publisher","award":["MO002\\u20132019"],"award-info":[{"award-number":["MO002\\u20132019"]}],"id":[{"id":"10.13039\/501100003093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003093","name":"Ministry of Higher Education, Malaysia","doi-asserted-by":"publisher","award":["TIDREC-2023"],"award-info":[{"award-number":["TIDREC-2023"]}],"id":[{"id":"10.13039\/501100003093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.vaccine.2026.128792","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T03:47:53Z","timestamp":1781236073000},"page":"128792","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Impact of confidence in scientific community, manufacturers, and regulatory authorities on acceptance of locally manufactured mRNA vaccines"],"prefix":"10.1016","volume":"88","author":[{"given":"Li Ping","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haridah","family":"Alias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai Yen","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.vaccine.2026.128792_bb0005","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41573-021-00283-5","article-title":"mRNA vaccines for infectious diseases: principles, delivery and clinical translation","volume":"20","author":"Chaudhary","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.vaccine.2026.128792_bb0010","author":"Malaysian Science and Technology Information Centre"},{"key":"10.1016\/j.vaccine.2026.128792_bb0015","series-title":"COVIDNOW: COVID-19 Vaccination in Malaysia","author":"Ministry of Health Malaysia","year":"2026"},{"key":"10.1016\/j.vaccine.2026.128792_bb0020","author":"Ministry of Health Malaysia"},{"key":"10.1016\/j.vaccine.2026.128792_bb0025","unstructured":"National Pharmaceutical Regulatory Agency (NPRA), Ministry of Health Malaysia; 2026.[Accessed May 19, 2026]. Available at: https:\/\/npra.gov.my\/index.php\/en. 2026."},{"key":"10.1016\/j.vaccine.2026.128792_bb0030","series-title":"PM launches National Vaccine Development Roadmap and Institute","author":"Bernama","year":"2021"},{"issue":"34","key":"10.1016\/j.vaccine.2026.128792_bb0035","doi-asserted-by":"crossref","first-page":"4165","DOI":"10.1016\/j.vaccine.2015.04.037","article-title":"Measuring vaccine hesitancy: the development of a survey tool","volume":"33","author":"Larson","year":"2015","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2026.128792_bb0040","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.4161\/hv.24657","article-title":"Vaccine hesitancy: an overview","volume":"9","author":"Dub\u00e9","year":"2013","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.vaccine.2026.128792_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1256829","article-title":"The impact of nontransparent health communication during the COVID-19 pandemic on vaccine-hesitant people\u2019s perception of vaccines","volume":"11","author":"Wegwarth","year":"2024","journal-title":"Front. Public Health"},{"key":"10.1016\/j.vaccine.2026.128792_bb0050","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s43856-022-00123-6","article-title":"Assessing the impact of novelty and conformity on hesitancy towards COVID-19 vaccines using mRNA technology","volume":"2","author":"Leong","year":"2022","journal-title":"Commun. Med. (Lond.)"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128792_bb0055","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41541-025-01143-8","article-title":"Global socioeconomic inequalities in vaccination coverage, supply, and confidence","volume":"10","author":"Wang","year":"2025","journal-title":"NPJ Vaccines"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128792_bb0060","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-048172","article-title":"Public acceptance of COVID-19 vaccines: cross-national evidence on levels and individual-level predictors using observational data","volume":"11","author":"Lindholt","year":"2021","journal-title":"BMJ Open"},{"issue":"11","key":"10.1016\/j.vaccine.2026.128792_bb0065","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1093\/trstmh\/trae048","article-title":"Trust in institutions affects vaccination campaign outcomes","volume":"118","author":"Leblang","year":"2024","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.vaccine.2026.128792_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2021.113684","article-title":"Trust in a COVID-19 vaccine in the U.S.: a social-ecological perspective","volume":"270","author":"Latkin","year":"2021","journal-title":"Soc. Sci. Med."},{"issue":"1","key":"10.1016\/j.vaccine.2026.128792_bb0075","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3390\/ijerph20010665","article-title":"The role of trust in COVID-19 vaccine acceptance: considerations from a systematic review","volume":"20","author":"Sapienza","year":"2022","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.vaccine.2026.128792_bb0080","series-title":"SmartPLS","author":"Ringle","year":"2015"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128792_bb0085","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1108\/IMDS-09-2015-0382","article-title":"Using PLS path modeling in new technology research: updated guidelines","volume":"166","author":"Henseler","year":"2016","journal-title":"Ind. Manag. Data Syst."},{"key":"10.1016\/j.vaccine.2026.128792_bb0090","series-title":"A primer on partial least squares structural equation modeling (PLS-SEM)","author":"Hair","year":"2017"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2026.128792_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lrp.2013.01.001","article-title":"Editorial-partial least squares structural equation modeling: rigorous technologys, better results and higher acceptance","volume":"46","author":"Hair","year":"2013","journal-title":"Long Range Plan."},{"issue":"1","key":"10.1016\/j.vaccine.2026.128792_bb0100","first-page":"7","article-title":"Structural equation modeling and regression: guidelines for research practice","volume":"2","author":"Gefen","year":"2000","journal-title":"Comm. Assoc. Info. Syst."},{"key":"10.1016\/j.vaccine.2026.128792_bb0105","series-title":"Structural equation modeling with AMOS: Basic concepts, application, and programming","author":"Byrne","year":"2010"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128792_bb0110","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1108\/EBR-11-2018-0203","article-title":"When to use and how to report the results of PLS-SEM","volume":"31","author":"Hair","year":"2019","journal-title":"Eur. Bus. Rev."},{"key":"10.1016\/j.vaccine.2026.128792_bb0115","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s11747-014-0403-8","article-title":"A new criterion for assessing discriminant validity in variance-based structural equation modeling","volume":"43","author":"Henseler","year":"2015","journal-title":"J. Acad. Mark. Sci."},{"key":"10.1016\/j.vaccine.2026.128792_bb0120","series-title":"Latent Variable Path Modeling With Partial Least Squares","author":"Lohm\u00f6ller","year":"1989"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128792_bb0125","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1037\/1082-989X.3.4.424","article-title":"Fit indices in covariance structure modeling: sensitivity to underparameterized model misspecifcation","volume":"3","author":"Hu","year":"1998","journal-title":"Psychol. Methods"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128792_bb0130","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1362\/146934709X467767","article-title":"Does my structural model represent the real phenomenon?: a review of the appropriate use of structural equation modelling (SEM) model fit indices","volume":"9","author":"Singh","year":"2009","journal-title":"Mark. Rev."},{"key":"10.1016\/j.vaccine.2026.128792_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvacx.2022.100213","article-title":"Trust is the common denominator for COVID-19 vaccine acceptance: a literature review","volume":"12","author":"Adhikari","year":"2022","journal-title":"Vaccine X"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128792_bb0140","doi-asserted-by":"crossref","first-page":"10416","DOI":"10.1038\/s41598-024-60788-y","article-title":"Information processing style and institutional trust as factors of COVID vaccine hesitancy","volume":"14","author":"Zhao","year":"2024","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.vaccine.2026.128792_bb0145","doi-asserted-by":"crossref","first-page":"834","DOI":"10.3390\/vaccines11040834","article-title":"COVID-19 anti-vaccine sentiments in Malaysia: narratives of comments from Facebook post","volume":"11","author":"Wong","year":"2023","journal-title":"Vaccines (Basel)"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128792_bb0150","doi-asserted-by":"crossref","first-page":"361","DOI":"10.24171\/j.phrp.2021.0085","article-title":"Factors influencing acceptance of the COVID-19 vaccine in Malaysia: a web-based survey","volume":"12","author":"Lau","year":"2021","journal-title":"Osong Public Health Res. Perspect."},{"key":"10.1016\/j.vaccine.2026.128792_bb0155","doi-asserted-by":"crossref","DOI":"10.3389\/fitd.2021.788188","article-title":"Sharia (Islamic law) perspectives of COVID-19 vaccines","volume":"2","author":"Mardian","year":"2021","journal-title":"Front. Trop. Dis."},{"key":"10.1016\/j.vaccine.2026.128792_bb0160","author":"Halal Advisory Group"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128792_bb0165","doi-asserted-by":"crossref","first-page":"298","DOI":"10.7774\/cevr.2023.12.4.298","article-title":"Barriers to measles mumps rubella vaccine acceptance in the three southern border provinces of Thailand","volume":"12","author":"Sirithammaphan","year":"2023","journal-title":"Clin. Exp. Vaccine Res."},{"issue":"1","key":"10.1016\/j.vaccine.2026.128792_bb0170","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1186\/s12889-019-6706-4","article-title":"Religious and community leaders\u2019 acceptance of rotavirus vaccine introduction in Yogyakarta, Indonesia: a qualitative study","volume":"19","author":"Padmawati","year":"2019","journal-title":"BMC Public Health"},{"issue":"9","key":"10.1016\/j.vaccine.2026.128792_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0266925","article-title":"COVID-19 vaccine hesitancy and its associated factors in Malaysia","volume":"17","author":"Lee","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2026.128792_bb0180","author":"OECD"},{"issue":"7","key":"10.1016\/j.vaccine.2026.128792_bb0185","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1016\/j.pec.2022.02.009","article-title":"Examining the direct and indirect effects of trust in motivating COVID-19 vaccine uptake","volume":"105","author":"Liu","year":"2022","journal-title":"Patient Educ. Couns."},{"issue":"3","key":"10.1016\/j.vaccine.2026.128792_bb0190","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3390\/vaccines1030204","article-title":"Sustaining vaccine confidence in the 21st century","volume":"1","author":"Hardt","year":"2013","journal-title":"Vaccines"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128792_bb0195","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1001\/jama.2013.58","article-title":"Restoring confidence in the pharmaceutical industry","volume":"309","author":"Bauchner","year":"2013","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128792_bb0200","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1186\/s12916-023-03113-0","article-title":"A 10-year update to the principles for clinical trial data sharing by pharmaceutical companies: perspectives based on a decade of literature and policies","volume":"21","author":"Modi","year":"2023","journal-title":"BMC Med."},{"key":"10.1016\/j.vaccine.2026.128792_bb0205","doi-asserted-by":"crossref","DOI":"10.1017\/S0950268822000255","article-title":"Trust in the scientific research community predicts intent to comply with COVID-19 prevention measures: an analysis of a large-scale international survey dataset","volume":"150","author":"Han","year":"2022","journal-title":"Epidemiol. Infect."},{"issue":"6","key":"10.1016\/j.vaccine.2026.128792_bb0210","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1177\/0963662517728478","article-title":"Scientists\u2019 views about communication objectives","volume":"27","author":"Besley","year":"2018","journal-title":"Public Underst. Sci."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26006018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26006018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:43:44Z","timestamp":1789505024000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26006018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":42,"alternative-id":["S0264410X26006018"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128792","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of confidence in scientific community, manufacturers, and regulatory authorities on acceptance of locally manufactured mRNA vaccines","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128792","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"128792"}}